US Bancorp
AFIB

US Bancorp’s Acutus Medical Inc AFIB Stock Holding History

US Bancorp’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$1.15K – 4223
2022
Q4 		$1.15K Hold
1,000
– – ﹤0.01% 3897
2022
Q3 		$1K Hold
1,000
– – ﹤0.01% 4037
2022
Q2 		$1K Hold
1,000
– – ﹤0.01% 4037
2022
Q1 		$1K Buy
+1,000
New +$2.14K ﹤0.01% 4030
2021
Q4 		– Sell
-1,388
Closed -$12K – 4260
2021
Q3 		$12K Buy
1,388
+1,176
+555% +$15.5K ﹤0.01% 3377
2021
Q2 		$4K Buy
+212
New +$3.1K ﹤0.01% 3692

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return

US Bancorp's AFIB Position: Q1 2023 in Review

US Bancorp sold out of Acutus Medical Inc (AFIB) in Q1 2023, closing a stake of 1,000 shares — an estimated $1.15K sold.

US Bancorp first reported a position in AFIB in Q2 2021 and held it in 6 quarters. The position peaked at $12K in Q3 2021. 38 funds tracked by Wall St. Rank hold AFIB as of Q1 2023.

  • US Bancorp reported no remaining Acutus Medical Inc position as of Q1 2023 after selling out during the quarter.
  • US Bancorp sold 1,000 Acutus Medical Inc shares in Q1 2023, an estimated $1.15K.
  • US Bancorp first reported a position in Acutus Medical Inc in Q2 2021 and held it in 6 quarters.
  • US Bancorp's Acutus Medical Inc position peaked at $12K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.